|
Genetix Limited, founded in 1991 by Mark Reid, develops genomics, proteomics, high-throughput screening (HTS), cell biology research equipment, consumables, reagents, and applications. The firm serves biotechnology and pharmaceutical companies, as well as academic research groups. It offers clients gene discovery, DNA sequencing, protein identification and separation, cell culture automation, and other products. Genetix went public in 2000. The company is listed on the London Stock Exchange. Also in 2000, the firm acquired Genpak Limited. Genetix is based in Hampshire, England. It maintains additional facilities in the United States and Germany.
|